Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.50 |
| ▸ | MAPT | P10636 | 4/20 | 0.50 |
| ▸ | LMNA | P02545 | 4/20 | 0.50 |
| ▸ | GAA | P10253 | 3/20 | 0.50 |
| ▸ | HTT | P42858 | 3/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.50 |
| ▸ | GLA | P06280 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | MAOA | P21397 | 2/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.50 |
| ▸ | CASP1 | P29466 | 1/20 | 0.50 |
| ▸ | CASP7 | P55210 | 1/20 | 0.50 |
| ▸ | S100A4 | P26447 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 3/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17987 | 0.96 | ALDH1A1 (0.48) | ALDH1A1KDM4ESMN1; SMN2MAPTLMNA | |
| SCHEMBL29362920 | 0.96 | ALDH1A1 (0.48) | ALDH1A1KDM4ESMN1; SMN2MAPTLMNA | |
| SCHEMBL6050558 | 0.96 | ALDH1A1 (0.48) | ALDH1A1KDM4ESMN1; SMN2MAPTLMNA | |
| SCHEMBL32671774 | 0.96 | ALDH1A1 (0.48) | ALDH1A1KDM4ESMN1; SMN2MAPTLMNA | |
| Water SCHEMBL592692 | 0.93 | ALDH1A1 (0.46) | ALDH1A1KDM4ESMN1; SMN2MAPTLMNA | |
| SCHEMBL4930798 | 0.93 | ALDH1A1 (0.46) | ALDH1A1KDM4ESMN1; SMN2MAPTLMNA | |
| SCHEMBL30139899 | 0.93 | ALDH1A1 (0.46) | ALDH1A1KDM4ESMN1; SMN2MAPTLMNA | |
| SCHEMBL5536637 | 0.93 | ALDH1A1 (0.46) | ALDH1A1KDM4ESMN1; SMN2MAPTLMNA | |
| SCHEMBL4921603 | 0.93 | ALDH1A1 (0.46) | ALDH1A1KDM4ESMN1; SMN2MAPTLMNA | |
| Water SCHEMBL29662270 | 0.93 | ALDH1A1 (0.46) | ALDH1A1KDM4ESMN1; SMN2MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2532660-B1 | Process for preparing chiral compounds | PFIZER PROD INC (US) | 2014-09-10 | — | — | EP | disclosed |
| US-20110003878-A1 | NOVEL DERIVATIVES OF PHTHALIMIDE AS HISTONE DEACETYLASE INHIBITORS | UNIVERSIDAD DE GRANADA (ES) | 2011-01-06 | — | — | US | disclosed |
| EP-2045239-A1 | NOVEL DERIVATIVES OF PHTHALIMIDE AS HISTONE DEACETYLASE INHIBITORS | Universidad De Granada (ES) | 2009-04-08 | — | — | EP | disclosed |
| US-20080165668-A1 | RECORDING MEDIUM AND INFORMATION RECORDING AND REPRODUCING METHOD USING THE SAME | FUJIFILM CORPORATION | 2008-07-10 | — | — | US | disclosed |
| WO-2008003801-A1 | NOVEL DERIVATIVES OF PHTHALIMIDE AS HISTONE DEACETYLASE INHIBITORS | UNIVERSIDAD DE GRANADA (ES) | 2008-01-10 | — | — | WO | disclosed |
| CN-101044028-A | Optical information recording medium | FUJI PHOTO FILM CO LTD (JP) | 2007-09-26 | — | — | CN | disclosed |
| US-20060194151-A1 | Recording medium and information recording and reproducing method using the same | FUJI PHOTO FILM CO., LTD. | 2006-08-31 | — | — | US | disclosed |
| US-7058001-B2 | Recording medium and information recording and reproducing method using the same | FUJI PHOTO FILM CO., LTD. (JP) | 2006-06-06 | — | — | US | disclosed |
| US-20050002835-A1 | Micro-engineered reactor | ASTRAZENECA AB (SE) | 2005-01-06 | — | — | US | disclosed |
| EP-1439904-A1 | A MICRO-ENGINEERED CHEMICAL REACTOR | AstraZeneca AB (SE) | 2004-07-28 | — | — | EP | disclosed |
| US-20020118627-A1 | Recording medium and information recording and reproducing method using the same | FUJIFILM CORPORATION (JP) | 2002-08-29 | — | — | US | disclosed |
| US-6437887-B1 | Optical logic device and optical memory device | FUJI PHOTO FILM CO., LTD. (JP) | 2002-08-20 | — | — | US | disclosed |
| EP-1130585-A2 | Recording medium and information recording and reproducing method using the same | Fuji Photo Film Co., Ltd. (JP) | 2001-09-05 | — | — | EP | disclosed |
| US-6203876-B1 | RADIATION TRANSPARENT LAYER ON RECORDING LAYER WITH ORGANIC DYE AND OXIDIZER | FUJI PHOTO FILM CO., LTD. (JP) | 2001-03-20 | — | — | US | disclosed |
| EP-1035428-A2 | Optical logic device and optical memory device | Fuji Photo Film Co., Ltd. (JP) | 2000-09-13 | — | — | EP | disclosed |
| US-5879772-A | Information recording medium | FUJI PHOTO FILM CO., LTD. (JP) | 1999-03-09 | — | — | US | disclosed |
| EP-0820057-A1 | Information recording medium | FUJI PHOTO FILM CO., LTD. (JP) | 1998-01-21 | — | — | EP | disclosed |
| US-5593970-A | ANTITUMOR AND ANTCARCINOGENIC AGENTS; TRETMENT OF CANCEROUS BONE MARROW BEFORE REGRAFTING | BIOCHEM PHARMA INC. (CA) | 1997-01-14 | — | — | US | disclosed |
| EP-0533744-A1 | HETEROCYCLIC ANTHRACYCLIONE AND ANTHRACYCLINE ANALOGS | BIOCHEM PHARMA INC. (CA) | 1993-03-31 | — | — | EP | disclosed |
| WO-1991019725-A2 | HETEROCYCLIC ANTHRACYCLIONE AND ANTHRACYCLINE ANALOGS | BIOCHEM PHARMA INC. (CA) | 1991-12-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110003878-A1 | NOVEL DERIVATIVES OF PHTHALIMIDE AS HISTONE DEACETYLASE INHIBITORS | HDAC1, HDAC2, HDAC11 | ALDH1A1 340/4885KDM4E 134/4885SMN1; SMN2 2910/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.